GMGasan M. Magomedov

Gasan M. Magomedov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gasan M. Magomedov has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    IMMEDIATE AND LONG-TERM RESULTS OF MINIMALLY INVASIVE ACCESS IN AORTIC VALVE SURGERY: SINGLE CENTER RETROSPECTIVE STUDY

    by Сослан Тайсумович Энгиноев, Alexander A. Ziankou, Гасан Магомедзагирович Магомедов, Тамара Кулумбековна Рашидова, Аминат Мухмад-Салиховна Умахановна, Аминат Руслановна Сатаева, Игорь Ионович Чернов, Владимир Николаевич Колесников, Александр Александрович Зеньков

    Highlights Mechanical aortic valve prostheses demonstrate significant long-term advantages in patients aged 50–65 years compared with bioprosthetic valves, including higher survival, a lower risk of reoperation, and a reduced incidence of prosthetic valve endocarditis. Both types of prostheses showed comparable outcomes with respect to postoperative complications, in-hospital mortality, and the incidence of stroke. These findings underscore the need for an individualized approach to prosthesis selection, taking into account patient age and concomitant risk factors.   Aim. To compare the immediate and long-term outcomes of aortic valve replacement (AVR) using mechanical and biological prostheses in patients aged 50–65 years. Methods. This retrospective study included data from 792 patients who underwent AVR with mechanical or biological prostheses between 2009 and 2019. After pseudorandomization, 374 patients were selected and divided into two groups: Group 1 (n = 187) – mechanical prostheses, Group 2 (n = 187) – biological prostheses. Inclusion criteria: age ≥ 18 years, isolated AVR. Exclusion criteria: left ventricular ejection fraction < 35%, double or triple valve replacement, age < 50 or > 65 years. The median follow-up period was 90 months (range: 53–118 months). Immediate and long-term outcomes were evaluated, including survival, reoperation rates, stroke incidence, and prosthetic endocarditis. Results. There were no statistically significant differences in immediate postoperative outcomes between the groups. The 1-, 3-, 5-, and 10-year survival rates in the mechanical prosthesis group were 94.9%, 93%, 89.7%, and 86.4%, respectively, which were higher than in the biological prosthesis group (93%, 88.7%, 84.2%, and 66.4%; p = 0.001). Freedom from reoperation at 1, 3, 5, and 10 years in the mechanical prosthesis group was 97.7%, 97.7%, 97.7%, and 97.7%, while in the biological prosthesis group, it was 98.3%, 96.9%, 95.4%, and 76.4% (p < 0.001). The incidence of stroke at 1, 3, 5, and 10 years in the mechanical prosthesis group was 2.7%, 5.4%, 5.4%, and 12.2%, while in the biological prosthesis group, it was 2.1%, 5.8%, 6.7%, and 9.4% (p = 0.486). Freedom from prosthetic endocarditis at 1, 3, 5, and 10 years in the mechanical prosthesis group was 100%, 100%, 100%, and 100%, while in the biological prosthesis group, it was 99.4%, 97.3%, 97.3%, and 94.5% (p = 0.003). Conclusion. Mechanical AV prostheses demonstrate significant long-term advantages in patients aged 50–65 years compared to biological prostheses. They are associated with higher survival rates, lower risks of reoperation, and reduced incidence of prosthetic endocarditis. However, both types of prostheses showed comparable results in terms of postoperative complications, in-hospital mortality, and stroke incidence. These findings highlight the importance of an individualized approach to prosthesis selection, taking into account patient age and associated risk factors.

  • Open Access

    COMPARISON OF ENDOSCOPIC AND OPEN GREAT SAPHENOUS VEIN HARVESTING IN OFF-PUMP CORONARY ARTERY BYPASS GRAFTING: A RETROSPECTIVE PROPENSITY SCORE-MATCHED STUDY

    by V. N. Kolesnikov, S. T. Enginoev, A. A. Ziankou, G. M. Magomedov, A. M.-S. Umakhanova, I. T. Aleroeva, I. I. Chernov, A. B. Gamzaev, В. Н. Колесников, С. Т. Энгиноев, et al.

    Цель: оценить непосредственные и отдалённые результаты эндоскопического и открытого забора БПВ при КШ на работающем сердце. Материалы и методы: выполнен ретроспективный одноцентровый анализ результатов КШ на работающем сердце у 1851 пациента, оперированного в период с 2009 по 2022 гг. В зависимости от методики забора БПВ пациенты были разделены на две группы: эндо- скопический забор БПВ — 115 пациентов и открытый забор БПВ — 1736 пациентов. Для минимизации влияния исходной неоднород- ности групп выполнена propensity score matching (PSM), после чего сформированы две сопоставимые группы по 114 пациентов. Оце- нивались интраоперационные показатели, ранние послеоперационные осложнения, госпитальная летальность и отдалённая выживаемость. Результаты: частота проблем с заживлением раны нижней конечности была статистически значимо ниже в группе эндоскопического забора БПВ по сравнению с открытым способом (0% против 8,8%; p<0,001). Различий по частоте периоперационного ИМ (1,8% про- тив 0,9%; p=1,0), инсульта (1,8% против 2,6%; p=1,0), ОПП (0,9% против 3,5%; p=0,369), ПОФП (9,6% против 10,5%; p=0,826) и госпи- тальной летальности (1,8% против 0,9%; p=1,0) выявлено не было. Медиана периода наблюдения составила 77 [10–125] месяцев. Десятилетняя выживаемость составила 86,0% в группе эндоскопического забора и 91,6% в группе открытого доступа без статистиче- ски значимых различий между кривыми Каплана–Мейера. Заключение: эндоскопический забор БПВ при КШ на работающем сердце является безопасной и клинически эффективной методи- кой, обеспечивающей значительное снижение частоты раневых осложнений нижней конечности без ухудшения непосредственных и отдалённых результатов хирургической реваскуляризации миокарда

  • Open Access

    Experience with the use of the heartstring device for proximal anastomosis in 1,720 patients undergoing off-pump coronary

    by В. Н. Колесников, С. Т. Энгиноев, A.A. Ziankou, Г. М. Магомедов, T.K. Rashidova, А. М-С. Умаханова, Д. Б. Алероев, I.I. Chernov, А. Б. Гамзаев

    Цель исследования: оценить непосредственные результаты применения устройства Heartstring при формировании проксимальных анастомозов у пациентов, перенесших изолированное коронарное шунтирование (КШ) на работающем сердце. Материалы и методы: проведён ретроспективный анализ 1720 пациентов, оперированных в период с 2009 г. по 2022 г. Изучались демографические характеристики, интраоперационные данные и непосредственные результаты послеоперационного периода. Все вмешательства выполнены без искусственного кровообращения, с использованием устройства Heartstring для проксимальных анастомозов. Оценивались частота инсульта, периоперационного инфаркта миокарда, осложнений, требующих реэксплорации, а также госпитальная летальность. Результаты: медиана возраста пациентов составила 63 (58–69) лет, мужчин — 88,3%. Атероматоз аорты выявлен у 54,3% больных. Медиана длительность операции составила 155 (135–180) минут, конверсия к искусственному кровообращению потребовалась в 0,6% случаев. Частота периоперационного инфаркта миокарда составила 1%, инсульта — 1,2%, острого почечного повреждения — 1,6%, реэксплорации по поводу кровотечения — 1,6%. Госпитальная летальность составила 0,9%. Использование устройства Heartstring позволило безопасно выполнить проксимальные анастомозы без пережатия аорты даже у пациентов с выраженным атероматозом, обеспечив низкий уровень неврологических и геморрагических осложнений. Заключение: применение устройства Heartstring при КШ на работающем сердце является надёжной и безопасной технологией, позволяющей снизить риск инсульта и других осложнений, связанных с манипуляциями на аорте. Методика может рассматриваться как эффективная альтернатива традиционному способу анастомозирования у пациентов с высоким риском атероэмболии.

  • Comparison between mini-access and median sternotomy for aortic valve replacement: propensity score matching analysis

    by S.T. Enginoev, G.M. Magomedov, A.A. Zenkov, T.M. Smagilaev, M.A. Guliev, I.I. Chernov

    Objective. To compare the immediate and long-term results of sternotomy and mini-approach for aortic valve replacement. Material and methods. A retrospective study included 718 patients who underwent isolated aortic valve replacement between April 2009 and December 2019. Propensity score matching was performed due to significant differences in clinical and demographic parameters. Two groups were distinguished: group I (sternotomy) — 67 patients, group II (mini-access) — 67 patients. Inclusion criteria: isolated aortic valve replacement, age ≥18 years. Exclusion criteria: Ross procedure, AVNeo, combined interventions, left ventricular ejection fraction≤40%, repeated interventions. The median follow-up period was 44 (7—80) months. Results. Duration of surgery, cardiopulmonary bypass and myocardial ischemia was similar in both groups (155 versus 165 min, p=0.4; 87 versus 92 min, p=0.4; 68 versus 70 min, p=0.4). There was no in-hospital mortality, stroke or perioperative myocardial injury. No significant difference was found in postoperative complications and length of ICU- and hospital-stay. Incidence of explorations for bleeding (3% vs 1.5%, p=0.9), pacemaker implantation (3% vs 1.5%, p=0.9), acute kidney injury (1.5% vs 0%, p=0.9) and sternal infection (0% vs 1.5%, p=0.9) was similar. One, 3-, 5- and 9-year survival was 100%, 100%, 94.7% and 81.5% after sternotomy, 100%, 91.1%, 85.9% and 85.9% after mini-access (p=0.34). Nine-year freedom from redo surgeries was 92% and 97%, respectively (p=0.84). Conclusion. There was no significant difference in immediate and long-term results.

  • Open Access

    IMMEDIATE AND LONG-TERM RESULTS OF MINIMALLY INVASIVE AORTIC VALVE REPLACEMENT: SINGLE CENTER RETROSPECTIVE STUDY

    by Сослан Тайсумович Энгиноев, Alexander A. Zenkov, Hasan M. Magomedov, Uzlipat K. Abdulmejidova, Шамиль Хаматханович Чертоев, Игорь Ионович Чернов

    HighlightsWe have conducted a retrospective analysis of patients who underwent minimally invasive aortic valve replacement, and evaluated immediate and long-term results of the surgery. AbstractAim. To study the immediate and long-term results of minimally invasive aortic valve (AV) replacement.Methods. The retrospective study included 208 patients with AV stenosis undergoing minimally invasive aortic valve replacement in the period from 2010 to 2019. The ratio of men to women was 1:1. The mean age of the patients was 63 (58–68) years old, with the minimum age being 29 years and the maximum being 81 years. The median follow-up period was 45.5 (11–68) months. Endpoints were as follows: hospital mortality, postoperative complications, long-term outcome (long-term survival, freedom from reoperation). Inclusion criteria were as follows: patients aged 18 years and older undergoing minimally invasive aortic valve replacement. Exclusion criteria were as follows: AVNeo, Ross procedure and AV replacement with aortic homograft, combined interventions (except for intervention on the ascending aorta), and standard access site.Results. The majority of patients (199 (95.7%) underwent “J”-shaped ministernotomy through the III-IV intercostal space. As a part of the combined intervention, ascending aorta replacement was performed in 6 (2.9%) patients. The duration of cardiopulmonary bypass and aortic cross-clamping was 91 (78–106) min and 68 (60–78) min, respectively. Due to conduction disorders, implantation of a pacemaker was performed in 5 (2.4%) patients, stroke was diagnosed in 1 (0.5%) patient, resternotomy for bleeding was performed in 4 (1.9%) patients, cardiac tamponade in 2 (1 %) patients, sternal infection was found in 1 (0.5%) patient. There were no complications such as AKI, perioperative MI, or hospital mortality in any patient. Five- and ten-year survival after surgical treatment of patients was 88.2% and 80.5%, respectively. Five- and ten-year freedom from reoperation on AV was 96.2% and 96.2%.Conclusions. Minimally invasive AV replacement is a measurable procedure with negligible complication rates. Minimally invasive aortic valve replacement has shown its effectiveness in the long-term period with acceptable rates of survival and freedom from reoperation.


  • Open Access

    Surgical treatment of aortic root abscess: 10-year single center experience

    by S. T. Enginoev, А. А. Зеньков, G. M. Magomedov, U. K. Abdulmejidova, M. A. Guliyev, I. I. Chernov, E. Yu. Gubareva

    The issue of optimal surgical scope in patients with aortic root abscess due to infective endocarditis remains open, since there are different strategies and interventional methods. In addition, the guidelines do not give preference to any particular type of surgical intervention and recommend an individual approach to each situation. The study included 25 patients with aortic root abscess due to aortic valve infective endocarditis. The most frequently performed surgical intervention in patients was the Ross procedure (n=12, 48%). Eight (32%) patients of the center underwent aortic homograft root replacement. Combined surgery was performed in 7 (28%) patients as follows: 3 (12%) patients — interventions on the mitral valve (all patients underwent mitral valve repair due to mitral valve involvement in abscess), 3 (12%) — coronary artery bypass grafting, 1 (4%) — ascending aortic replacement due to dilatation. Five- and ten-year survival after surgical treatment of patients with aortic root abscess was 86,9% and 78,6%, respectively. There was no reintervention and recurrence of infective endocarditis in the long-term period.


  • Open Access

    Surgical treatment of aortic root abscess: 10-year single center experience

    by S. T. Enginoev, А. А. Зеньков, G. M. Magomedov, U. K. Abdulmejidova, M. A. Guliyev, I. I. Chernov, E. Yu. Gubareva

    The issue of optimal surgical scope in patients with aortic root abscess due to infective endocarditis remains open, since there are different strategies and interventional methods. In addition, the guidelines do not give preference to any particular type of surgical intervention and recommend an individual approach to each situation. The study included 25 patients with aortic root abscess due to aortic valve infective endocarditis. The most frequently performed surgical intervention in patients was the Ross procedure (n=12, 48%). Eight (32%) patients of the center underwent aortic homograft root replacement. Combined surgery was performed in 7 (28%) patients as follows: 3 (12%) patients — interventions on the mitral valve (all patients underwent mitral valve repair due to mitral valve involvement in abscess), 3 (12%) — coronary artery bypass grafting, 1 (4%) — ascending aortic replacement due to dilatation. Five- and ten-year survival after surgical treatment of patients with aortic root abscess was 86,9% and 78,6%, respectively. There was no reintervention and recurrence of infective endocarditis in the long-term period.


  • Ten-year results of the Ross procedure in patients with infective endocarditis: a single-center retrospective study

    by I.I. Chernov, S.T. Enginoev, D.A. Kondratiev, G.M. Magomedov, T.K. Rashidova, A.A. Abdurakhmanov, D.G. Tarasov

    Objective. To analyze the immediate and long-term results of the Ross procedure in patients with infective endocarditis of the aortic valve. Material and methods. There were 53 patients with aortic valve infective endocarditis (43 (81%) men and 10 (19%) women). Inclusion criterion: patients who underwent the Ross procedure, age ≥18 years. Exclusion criteria: non-infectious aortic valve disease. Mean age of patients was 34.6±9.4 years. There were 3 (5.6%) patients with active infective endocarditis, and 12 (22.6%) ones had aortic root abscess. The median follow-up period was 80 [19; 116] months. Results. Combined interventions were performed in 12 (22.6%) cases. There was no in-hospital and 30-day mortality. In early postoperative period, 2 (3.8%) patients required implantation of a permanent pacemaker due to conduction disturbances. Two (3.8%) patients developed perioperative myocardial injury and acute renal injury requiring renal replacement therapy. Re-sternotomy for bleeding was performed in 3 (5.7%) patients. Ten-year overall survival, freedom from redo surgery and recurrence of infective endocarditis were 92.6%, 92.4% and 100%, respectively. In long-term period, median of mean pressure gradient was 3 [2; 3] mm Hg, aortic regurgitation ≥2 was observed in in 2 (6%) patients. Conclusion. The Ross surgery in young patients with aortic valve infective endocarditis is a safe technique in experienced hands with excellent long-term results.


  • Open Access

    Surgical treatment of cardiac echinococcosis: a case report

    by I. I. Chernov, D. Yu. Kozmin, V. V. Demetskaya, G. M. Magomedov, S. T. Enginoev

    Echinococcosis refers is a chronic disease caused by tapeworms of the order Cyclophyllidea. Echinococcal cysts increase in size slowly and are often asymptomatic, and the symptoms of cardiac echinococcosis are nonspecific, which in turn can make diagnosis difficult. Early diagnosis and surgical treatment of this disease is crucial to prevent severe complications. Considering that the heart is affected extremely rarely, we want to demonstrate the successful surgical treatment.